![Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma]()
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaRichardson, P. G.; Weller, E.; Lonial, S.; Jakubowiak, A. J.; Jagannath, S.; Raje, N. S.; Avigan, D. E.; Xie, W.; Ghobrial, I. M.; Schlossman, R. L.; Mazumder, A.; Munshi, N. C.; Vesole, D. H.; Joyce, R.; Kaufman, J. L.; Doss, D.; Warren, D. L.; Lunde, L. E.; Kaster, S.; DeLaney, C.; Hideshima, T.; Mitsiades, C. S.; Knight, R.; Esseltine, D.-L.; Anderson, K. C. · Blood · 2010